Skip to main content

La pénurie de sérums antivenimeux

Bulletin de la Société de pathologie exotique volume 109, pages 1–3 (2016)Cite this article

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Références

  1. Bochner R (2009) Premier dialogue scientifique entre le Brésil et la France: Vital Brazil et la naissance de l’Institut Butantan. Biofutur 300:74–5

    Google Scholar 

  2. Chippaux JP (2002) The treatment of snake bites: analysis of requirements and assessment of therapeutic efficacy in tropical Africa. In: Perspectives in molecular toxinology (A Ménez ed), 1 vol, John Wiley and Sons LTD, Chichester, UK, 457–72

    Google Scholar 

  3. Chippaux JP (2008) La crise actuelle de la sérothérapie antivenimeuse. Biofutur 292:45–8

    Google Scholar 

  4. Chippaux JP (2010) Immunothérapie d’urgence: antivenins de serpents et de scorpions. Biol Aujourd’hui 204 (1):61–70

    Article  CAS  Google Scholar 

  5. Chippaux JP (2012) African Society of Toxinology: a new opportunity for integrating the control of envenomations in Africa. J Venom Toxins incl. Trop Dis 18:357–60

    Article  Google Scholar 

  6. Chippaux JP, Goyffon M (1983) Producers of antivenomous sera. Toxicon 21 (6):739–52

    Article  CAS  PubMed  Google Scholar 

  7. Goyffon M (2008) Sérums antivenimeux. Dossier (4 articles). Biofutur 292:31–48

    Google Scholar 

  8. Gutiérrez JM (2016) Understanding and confronting snakebite envenoming: The harvest of cooperation. Toxicon 109:51–62

    Article  PubMed  Google Scholar 

  9. Mion G, Olive F, Rüttimann M, Saïssy JM (2000) Impact des venins de vipéridés. In: Les envenimations graves (G Mion, M Goyffon, eds), 1 vol, Arnette-Groupe-Liaisons SA, Rueil-Malmaison, France, p. 9–15

    Google Scholar 

  10. Musset Alfred de (1840) Premières poésies. Gallimard (La Pléiade 1951), p. 248-278

  11. Phisalix C, Bertrand G (1894) Sur la propriété antitoxique du sang des animaux vaccinés contre le venin de vipère. CR Soc Biol 46:111–3

    Google Scholar 

  12. Simpson ID, Blaylock RSM (2009) The anti snake venom crisis in Africa: a suggested manufacturers product guide. Wilderness Envirom Med 20 (3):275–82

    Article  Google Scholar 

  13. Theakston RDG, Warrell DA (1991). Antivenoms: a list of hyperimmune sera currently available for the treatment of envenomings by bites and stings. Toxicon 29 (12):1419–70

    Article  CAS  PubMed  Google Scholar 

  14. Warrell DA (2008) Unscrupulous marketing of snake bite antivenoms in Africa and Papua New Guinea: choosing the right product -’ what’s in a name?’ Trans Roy Soc Trop Med Hyg 102 (5):397–9

    Article  PubMed  Google Scholar 

  15. Williams D, Gutiérrez JM, Harrison R, et al (2010) The Global Snake Bite Initiative: an antidote for snake bite. Lancet 375 (9708):89–91

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Attaché honoraire du Muséum national d’Histoire naturelle, 57, rue Cuvier, 75005, Paris, France

    M. Goyffon

Authors
  1. M. Goyffon
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Goyffon.

About this article

Verify currency and authenticity via CrossMark

Cite this article

Goyffon, M. La pénurie de sérums antivenimeux. Bull. Soc. Pathol. Exot. 109, 1–3 (2016). https://doi.org/10.1007/s13149-016-0470-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13149-016-0470-9

Keywords

  • Snake Bite
  • Venom Toxin
  • Hyperimmune Seron
  • Cette Situation
  • Diver Producteurs